These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 6939913

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Enhancement of T cell-mediated immune responses in KMT-17-bearing rats by treatment with bleomycin].
    Xu ZY.
    Hokkaido Igaku Zasshi; 1987 Mar; 62(2):279-88. PubMed ID: 2440789
    [Abstract] [Full Text] [Related]

  • 4. The therapeutic effect of the antileukemia drug busulfan as an immunomodulator on transplanted fibrosarcoma KMT-17 in WKA rats.
    Mizushima Y, Koga Y, Yuhki N, Kobayashi H.
    Gan; 1983 Feb; 74(1):162-8. PubMed ID: 6840435
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous regression of syngeneic transplanted tumors in rats pretreated with the antileukemia drug busulfan.
    Sendo F, Miyake T, Fuyama S, Arai S.
    J Natl Cancer Inst; 1978 Feb; 60(2):385-9. PubMed ID: 621755
    [Abstract] [Full Text] [Related]

  • 6. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
    Minami A, Kasai M, Mizushima Y, Takeichi N, Hosokawa M, Kobayashi H.
    Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
    [Abstract] [Full Text] [Related]

  • 7. Overcoming suppression of antitumor immune reactivity in tumor-bearing rats by treatment with bleomycin.
    Xu ZY, Hosokawa M, Morikawa K, Hatakeyama M, Kobayashi H.
    Cancer Res; 1988 Dec 01; 48(23):6658-63. PubMed ID: 2460226
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma.
    Morikawa K, Hosokawa M, Hamada J, Sugawara M, Kobayashi H.
    Cancer Res; 1985 Apr 01; 45(4):1502-6. PubMed ID: 2579730
    [Abstract] [Full Text] [Related]

  • 11. Possible participation of tumoricidal macrophages in the therapeutic effect of bleomycin on a transplantable rat fibrosarcoma.
    Morikawa K, Hosokawa M, Hamada J, Xu ZY, Kobayashi H.
    Cancer Res; 1986 Feb 01; 46(2):684-8. PubMed ID: 2416431
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K, Morimoto M, Nomoto K.
    Cancer Res; 1982 Oct 01; 42(10):4197-202. PubMed ID: 6980702
    [Abstract] [Full Text] [Related]

  • 13. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
    Kawase I, Uemiya M, Yoshimoto T, Ogura T, Hirao F, Yamamura Y.
    Cancer Res; 1981 Feb 01; 41(2):660-6. PubMed ID: 6969630
    [Abstract] [Full Text] [Related]

  • 14. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system].
    Ebina T, Shishido K, Murata K.
    Gan To Kagaku Ryoho; 1990 Jul 01; 17(7):1345-50. PubMed ID: 2369138
    [Abstract] [Full Text] [Related]

  • 15. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID.
    J Immunol; 1977 Jan 01; 118(1):122-8. PubMed ID: 830744
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S, Greene MI, Sehon AH.
    J Immunol; 1976 Mar 01; 116(3):791-9. PubMed ID: 1082894
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Kurimoto M.
    Cancer Res; 1997 Oct 15; 57(20):4557-63. PubMed ID: 9377569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.